169 related articles for article (PubMed ID: 19675167)
61. Bone marrow CD8 cells down-modulate membrane IL-7Ralpha expression and exhibit increased STAT-5 and p38 MAPK phosphorylation in the organ environment.
Cassese G; Parretta E; Pisapia L; Santoni A; Guardiola J; Di Rosa F
Blood; 2007 Sep; 110(6):1960-9. PubMed ID: 17510323
[TBL] [Abstract][Full Text] [Related]
62. Intestinal epithelial antigen induces mucosal CD8 T cell tolerance, activation, and inflammatory response.
Liu Z; Lefrançois L
J Immunol; 2004 Oct; 173(7):4324-30. PubMed ID: 15383561
[TBL] [Abstract][Full Text] [Related]
63. Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size.
Liu SD; Tomassian T; Bruhn KW; Miller JF; Poirier F; Miceli MC
J Immunol; 2009 May; 182(9):5283-95. PubMed ID: 19380775
[TBL] [Abstract][Full Text] [Related]
64. STAT5-mediated signals sustain a TCR-initiated gene expression program toward differentiation of CD8 T cell effectors.
Verdeil G; Puthier D; Nguyen C; Schmitt-Verhulst AM; Auphan-Anezin N
J Immunol; 2006 Apr; 176(8):4834-42. PubMed ID: 16585578
[TBL] [Abstract][Full Text] [Related]
65. Differential regulation of peripheral CD4+ T cell tolerance induced by deletion and TCR revision.
Ali M; Weinreich M; Balcaitis S; Cooper CJ; Fink PJ
J Immunol; 2003 Dec; 171(11):6290-6. PubMed ID: 14634147
[TBL] [Abstract][Full Text] [Related]
66. The Ubiquitin Ligase Adaptor NDFIP1 Selectively Enforces a CD8
Wagle MV; Marchingo JM; Howitt J; Tan SS; Goodnow CC; Parish IA
Cell Rep; 2018 Jul; 24(3):577-584. PubMed ID: 30021156
[TBL] [Abstract][Full Text] [Related]
67. CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation.
Thomas MJ; Noble A; Sawicka E; Askenase PW; Kemeny DM
J Immunol; 2002 Jan; 168(1):216-23. PubMed ID: 11751965
[TBL] [Abstract][Full Text] [Related]
68. Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling.
Oberle N; Eberhardt N; Falk CS; Krammer PH; Suri-Payer E
J Immunol; 2007 Sep; 179(6):3578-87. PubMed ID: 17785792
[TBL] [Abstract][Full Text] [Related]
69. Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo.
Redmond WL; Gough MJ; Weinberg AD
Eur J Immunol; 2009 Aug; 39(8):2184-94. PubMed ID: 19672905
[TBL] [Abstract][Full Text] [Related]
70. IL-2 down-regulates the expression of TCR and TCR-associated surface molecules on CD8(+) T cells.
Kambayashi T; Assarsson E; Chambers BJ; Ljunggren HG
Eur J Immunol; 2001 Nov; 31(11):3248-54. PubMed ID: 11745341
[TBL] [Abstract][Full Text] [Related]
71. Deletion, but not anergy, is involved in TGF-beta-treated antigen-presenting cell-induced tolerance.
Alard P; Clark SL; Kosiewicz MM
Int Immunol; 2003 Aug; 15(8):945-53. PubMed ID: 12882832
[TBL] [Abstract][Full Text] [Related]
72. T cell effector function and anergy avoidance are quantitatively linked to cell division.
Wells AD; Walsh MC; Sankaran D; Turka LA
J Immunol; 2000 Sep; 165(5):2432-43. PubMed ID: 10946268
[TBL] [Abstract][Full Text] [Related]
73. B cell-deficient (mu MT) mice have alterations in the cytokine microenvironment of the gut-associated lymphoid tissue (GALT) and a defect in the low dose mechanism of oral tolerance.
Gonnella PA; Waldner HP; Weiner HL
J Immunol; 2001 Apr; 166(7):4456-64. PubMed ID: 11254701
[TBL] [Abstract][Full Text] [Related]
74. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo.
Sundstedt A; O'Neill EJ; Nicolson KS; Wraith DC
J Immunol; 2003 Feb; 170(3):1240-8. PubMed ID: 12538682
[TBL] [Abstract][Full Text] [Related]
75. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
76. Cutting edge: contributions of apoptosis and anergy to systemic T cell tolerance.
Barron L; Knoechel B; Lohr J; Abbas AK
J Immunol; 2008 Mar; 180(5):2762-6. PubMed ID: 18292495
[TBL] [Abstract][Full Text] [Related]
77. CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance.
Keino H; Masli S; Sasaki S; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1533-42. PubMed ID: 16565389
[TBL] [Abstract][Full Text] [Related]
78. Anergy induction by dimeric TCR ligands.
Appel H; Seth NP; Gauthier L; Wucherpfennig KW
J Immunol; 2001 Apr; 166(8):5279-85. PubMed ID: 11290814
[TBL] [Abstract][Full Text] [Related]
79. B220+ double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production.
Hamad AR; Mohamood AS; Trujillo CJ; Huang CT; Yuan E; Schneck JP
J Immunol; 2003 Sep; 171(5):2421-6. PubMed ID: 12928389
[TBL] [Abstract][Full Text] [Related]
80. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance.
Antov A; Yang L; Vig M; Baltimore D; Van Parijs L
J Immunol; 2003 Oct; 171(7):3435-41. PubMed ID: 14500638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
